Zoë A Hughes

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Mesenchymal Stem Cells

Major Depressive Disorder

Top Venues

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Adam K Klein, Eric W Austin, Michael J Cunningham, Dino Dvorak, Silvia Gatti, Sarah K Hulls, Laszlo Kiss, Andrew C Kruegel, Gerard J Marek, Mariusz Papp, Jonathan Sporn, Zoë A Hughes
GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2024)
Adam K Klein, Eric W Austin, Michael J Cunningham, Dino Dvorak, Silvia Gatti, Sarah K Hulls, Laszlo Kiss, Andrew C Kruegel, Gerard J Marek, Mariusz Papp, Jonathan Sporn, Zoë A Hughes
GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 49 (6) (2024)
Adam K Klein, Eric W Austin, Michael J Cunningham, Dino Dvorak, Silvia Gatti, Sarah K Hulls, Laszlo Kiss, Andrew C Kruegel, Gerard J Marek, Mariusz Papp, Jonathan Sporn, Zoë A Hughes
GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 49 (6) (2024)
Adam K Klein, Eric W Austin, Michael J Cunningham, Dino Dvorak, Silvia Gatti, Sarah K Hulls, Laszlo Kiss, Andrew C Kruegel, Gerard J Marek, Mariusz Papp, Jonathan Sporn, Zoë A Hughes
GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2024)
Adam K Klein, Eric W Austin, Michael J Cunningham, Dino Dvorak, Silvia Gatti, Sarah K Hulls, Laszlo Kiss, Andrew C Kruegel, Gerard J Marek, Mariusz Papp, Jonathan Sporn, Zoë A Hughes
GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 49 (6) (2024)
Adam K Klein, Eric W Austin, Michael J Cunningham, Dino Dvorak, Silvia Gatti, Sarah K Hulls, Laszlo Kiss, Andrew C Kruegel, Gerard J Marek, Mariusz Papp, Jonathan Sporn, Zoë A Hughes
GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 49 (6) (2024)
Adam K Klein, Eric W Austin, Michael J Cunningham, Dino Dvorak, Silvia Gatti, Sarah K Hulls, Laszlo Kiss, Andrew C Kruegel, Gerard J Marek, Mariusz Papp, Jonathan Sporn, Zoë A Hughes
GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 49 (6) (2024)